Alison Pelletier
Psychiatric/Mental Health · Beverly, MANPI 1023619699
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,799, more than ten times the $36 reported in 2021. Among psychiatric/mental health clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$526
- AbbVie$457
- Collegium Pharmaceutical, Inc.$324
- Corium, LLC$176
- Vanda Pharmaceuticals Inc.$153
- Supernus Pharmaceuticals, Inc.$142
- plus $669 from 12 others
What the payments were for
- Food & beverage$2,447100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 28 | $526 |
| AbbVie | 25 | $457 |
| Collegium Pharmaceutical, Inc. | 24 | $324 |
| Corium, LLC | 12 | $176 |
| Vanda Pharmaceuticals Inc. | 11 | $153 |
| Supernus Pharmaceuticals, Inc. | 6 | $142 |
| Ironshore Pharmaceuticals Inc. | 5 | $124 |
| Lundbeck LLC | 5 | $123 |
| Otsuka America Pharmaceutical, Inc. | 1 | $116 |
| GSK | 4 | $84 |
| Neurocrine Biosciences, Inc. | 3 | $53 |
| Pfizer | 2 | $44 |
| Exeltis, USA Inc. | 1 | $30 |
| Kaleo, Inc. | 1 | $24 |
| Organon | 1 | $21 |
| AstraZeneca | 1 | $19 |
| Alkermes, Inc. | 1 | $16 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,447 in reported general payments places this provider in the 90th percentile of 1,284 psychiatric/mental health providers in Massachusetts.
See all psychiatric/mental health providers in Massachusetts →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AmantadineAmantadine Hcl | 11 | $869 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Beverly
- Brianne LienkampMarion$121K
- Ashley BakerQuincy$54K
- Brian BanksPembroke$47K
- Anne-Margaret BotelhoMattapoisett$46K
- Matthew PeculisWalpole$41K
- Sherrie UrenaWorcester$21K
- Irina DauphineeHanover$18K
- Schree PettigrewNew Bedford$18K
- Sherryl RosenLynn$16K
- Kevin NardoneWorcester$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.